Clinical Trials Browser

Metastatic Digestive System Neuroendocrine Tumor G1

Advanced Lung Neuroendocrine Tumor

Neoplasm Metastasis

Thymus Neoplasms, Neuroendocrine Tumors

Diffuse Intrinsic Pontine Glioma, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

Diffuse Intrinsic Pontine Glioma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Tuberous Sclerosis, Neuroendocrine Tumors

Gastro-enteropancreatic neuroendocrine tumor, Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors

Neoplasm Metastasis

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Gastroenteropancreatic Neuroendocrine Tumors

Neoplasm Metastasis

Glioblastoma, Recurrence

Lymphangioleiomyomatosis

Locally Advanced Thyroid Gland Carcinoma

Breast Neoplasms

Gallbladder Neoplasms

Carcinoma, Hepatocellular

Carcinoid Tumor, Adenoma, Islet Cell, Neuroendocrine Tumors, Disease Progression

Carcinoma, Renal Cell

Breast Neoplasms

Carcinoma, Renal Cell, Kidney Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

HR+/HER2- Advanced Breast Cancer

Colorectal Neoplasms

Clinical Trials

Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

LEVEL

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

STELLAR-311

MOMENTUM-1

BIOMEDE 2

Sapu003 in Advanced mTOR-sensitive Solid Tumors

ACTION-1

GERTRUDE

ESMART

A Phase Ib/II Study to Evaluate Multiple Combination Therapies of FWD1802 in Patients With ER+/HER2- BC

LITESPARK-029

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

LUMEN-1

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

MOST plus

Pilot Trial for Treatment of Recurrent Glioblastoma

ELUMEN

MIDAS

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

SNF Platform Study of HR+/ HER2-advanced Breast Cancer

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

EVENET

Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

BCTOP-L-M01

Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

BCTOP-T-M03

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

EVIDENT